Marker Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -0.7361 | -100% |
| P/S |
|
10.56 | 33.44 | -68.41% |
|
|
| P/BV |
|
2.49 | 4.64 | -46.4% |
|
|
| P/FCF |
|
-2.12 | 42.53 | -104.99% |
|
|
| Ev/Ebitda |
|
-1.36 | -17.68 | -92.29% |
|
|
| Ev/S |
|
6 | 22.59 | -73.45% |
|
|
| Ev/FCF |
|
-1.21 | 47.55 | -102.54% |
|
|
| E/P |
|
-0.4862 | 0.0182 | -2771.43% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-440.37 | -14.2 | 3000.41% | -1981.07 | -77.77% |
| ROE |
|
-120.75 | 9.78 | -1334.31% |
|
|
| ROA |
|
-99.07 | 0.33 | -30117.12% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-512.46 | -26.41 | 1840.12% |
|
|
| ROCE |
|
-123.61 | 14.55 | -949.61% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5212 | -3.87 | -86.54% | -0.4086 | +27.56% |
| Nеt Debt/Ebitda |
|
1.04 | -4.24 | -124.44% |
|
|
| Debt/Ratio |
|
0.4437 | 0.1853 | 139.48% |
|
|
| Debt/Equity |
|
0.4578 | 1.61 | -71.5% |
|
|
| Debt/Net Income |
|
-0.4479 | 10.06 | -104.45% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.48 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1453.11 | 30.62 | 4645.62% | ||
| Growth impulse Ebitda in 5 years |
|
-47.03 | -17.42 | 169.98% | ||
| Growth impulse Net Income in 5 years |
|
-30.84 | -52.26 | -40.99% | ||
| Growth impulse FCF in 5 years |
|
-11.89 | -31.68 | -62.47% | ||
| Growth impulse EPS in 5 years |
|
-64.21 | -61.82 | 3.87% |
IP Score
3.25/10
